Shoreline Biosciences
PrivateLast Round
Series B
Nov 2, 2021
Est. Valuation
$68.3M
Total Funding Raised
$186M
Company Overview
Shoreline Biosciences is a biotechnology company that develops innovative immunotherapies utilizing engineered Induced Pluripotent Stem Cells (iPSC)-derived NK cells and macrophages for oncology and disease modification.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shoreline Biosciences Comparables
Compare Shoreline Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CytoImmune Therapeutics | 85% | |
| HebeCell | 85% | |
| CellOrigin Biotech | 84% | |
Shoreline Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 2, 2021 | ||||
| Series A | Apr 7, 2021 | ||||
| Seed | Jul 1, 2020 |
Shoreline Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Stork Capital | Series B, Series A, Seed |
| Janus Henderson Group | Series B, Series A |
| Wedbush Healthcare Partners | Series B, Series A |
| Boxer Capital | Series B, Series A |
| Ally Bridge Group | Series B |
| Heartland Healthcare Capital | Series B |
| Cormorant Asset Management | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2021
$140M round led by Ally Bridge Group
Shoreline Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shoreline Biosciences's valuation, stock price, and market status.